These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy. Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368 [TBL] [Abstract][Full Text] [Related]
6. Local conjunctival immunotherapy: the effect of dermatophagoides pteronyssinus local conjunctival immunotherapy on conjunctival provocation test in patients with allergic conjunctivitis. Núñez JA; Cuesta U Allergol Immunopathol (Madr); 2000; 28(6):301-6. PubMed ID: 11269896 [TBL] [Abstract][Full Text] [Related]
9. Lability of blocking antibody during ragweed immunotherapy. Wagner CJ; Taylor RJ; Nelson HS Ann Allergy; 1983 Jan; 50(1):19-22. PubMed ID: 6600384 [TBL] [Abstract][Full Text] [Related]
10. Incidence and characteristics of biphasic reactions after allergen immunotherapy. Scranton SE; Gonzalez EG; Waibel KH J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282 [TBL] [Abstract][Full Text] [Related]
11. Advances in upper airway diseases and allergen immunotherapy. Nelson HS J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953 [TBL] [Abstract][Full Text] [Related]
12. The safety of allergen immunotherapy: a literature review. Cook PR; Farias C Ear Nose Throat J; 1998 May; 77(5):378-9, 383-8. PubMed ID: 9615518 [TBL] [Abstract][Full Text] [Related]
16. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782 [TBL] [Abstract][Full Text] [Related]
17. Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions. Creticos PS; Lichtenstein LM Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):304-12; discussion 312-3. PubMed ID: 15119051 [TBL] [Abstract][Full Text] [Related]
18. Dose adjustment practices among allergists for local reactions to immunotherapy. Coop CA; Tankersley MS Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834 [TBL] [Abstract][Full Text] [Related]